ArticleAmerican journal of cancer research2023

Onvansertib inhibits the proliferation and improves the cisplatin-resistance of lung adenocarcinoma via β-catenin/c-Myc signaling pathway.

Rong Wang et al.PubMed ↗Full text ↗

No numbers read from the abstract.